Back to top

Moderna rises after starting phase 1 trial of Ebola vaccine

Moderna rises after starting phase 1 trial of Ebola vaccine

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Moderna, Inc. (MRNA)